INTRODUCTION
============

Lower urinary tract symptoms (LUTS) include a spectrum of storage, voiding, and postmicturition symptoms \[[@b1-inj-19-2-120]\]. These conditions negatively affect many aspects of health-related quality of life (HRQoL), including social and emotional well-being, work productivity, and sexual health \[[@b2-inj-19-2-120],[@b3-inj-19-2-120]\]. LUTS could be a sign of underlying medical pathophysiology, including cardiovascular disease and sleep apnea \[[@b4-inj-19-2-120],[@b5-inj-19-2-120]\]. In fact, the impact of severe LUTS on many dimensions of HRQoL may be similar to that of chronic conditions such as hypertension, diabetes, angina, and gout \[[@b6-inj-19-2-120]\]. LUTS in men might be suggestive of overactive bladder (OAB) and/or bladder outlet obstruction associated with benign prostatic hyperplasia \[[@b7-inj-19-2-120]\] and are believed to be common. Previous reports have estimated the overall prevalence of any LUTS to be 63%--83% in adult men \[[@b8-inj-19-2-120],[@b9-inj-19-2-120]\]. Because LUTS are highly prevalent in men and increase with age, the population burden of these conditions is likely to increase in the near future as demographics shift. Understanding the burden of LUTS is important for improved clinical practice and public health \[[@b10-inj-19-2-120]\].

To date, although epidemiologic studies of LUTS have been performed in many countries \[[@b2-inj-19-2-120],[@b3-inj-19-2-120],[@b9-inj-19-2-120],[@b11-inj-19-2-120]-[@b13-inj-19-2-120]\], there is a lack of epidemiologic data in Korean men. To gain more comprehensive and representative information on the prevalence and impact of LUTS in Korea, we conducted a population-based epidemiologic survey. The objective of the present study was to assess the impact of LUTS on HRQoL in men aged ≥40 years in Korea.

MATERIALS AND METHODS
=====================

A population-based, cross-sectional door-to-door survey of men aged ≥40 years was carried out in Korea to evaluate the prevalence of LUTS as well as to examine the impact of LUTS on various dimensions of HRQoL, including generic health status, work productivity, depressive symptoms, and sexual health. Only the results of the impact of LUTS are reported in the present study; the results of the prevalence of LUTS have been previously published \[[@b8-inj-19-2-120]\].

More than 1,800 men aged ≥40 years from five Korean provinces (Seoul, Busan, Daegu, Daejeon, and Gwangju) were targeted for recruitment. A random sample was obtained through the Post and Address Registry of Korea using a two-stage sampling method based on geographical variables. Those who reported currently having a urinary tract infection were excluded from this survey. After obtaining informed consent, interviews were conducted by direct interviews, usually in the respondent's home. To conduct the survey, the interviewer training in general lasted approximately two days before interviewers were authorized to start interviewing study participants. They were regularly tested to maintain consistency and quality control in the use of the questionnaires. This study was approved by our Institutional Review Board of the Samsung Medical Center (IRB No. 2010-02-026).

The questionnaire was divided into two parts: an initial questionnaire about demographics and presence of LUTS that was originally developed for a previous EPIC study \[[@b9-inj-19-2-120]\], and it was translated into an appropriate Korean version \[[@b14-inj-19-2-120]\]. Based on an initial questionnaire, individuals with LUTS were defined as men reporting at least one LUTS using 2002 International Continence Society definitions. An additional questionnaire consisted of questions about detailed demographics and comorbidity, generic QoL (EuroQoL-five-dimensions \[EQ-5D\] questionnaire), work productivity (work productivity and activity impairment \[WPAI\] questionnaire), depressive symptoms (center for epidemiologic studies depression scale, CES-D), and sexual satisfaction and erectile dysfunction (ED).

Generic QoL
-----------

The EQ-5D questionnaire is a well-validated comprehensive tool designed to measure generic HRQoL \[[@b15-inj-19-2-120]\]. The EQ-5D questionnaire has two components: the EQ-5D index and EQ-visual analogue scale (VAS). The EQ-5D index comprised a questionnaire with five dimensions: mobility, self-care, usual activities, pain or discomfort, and anxiety or depression. For each of the dimensions, the responder can choose from three different options; no problem, some/moderate problem, or extreme problem. A unique EQ-5D health state is defined by combining one level from each of the five dimensions with Korean weight-based scores ranging from 0.229 to 1.000, with higher scores indicating better overall health status \[[@b16-inj-19-2-120]\]. The EQ-VAS produces patients' self-perceived estimate of their HRQoL on a 100-point scale (0=worst imaginable health state to 100=best imaginable health state).

Work Productivity
-----------------

Participants were asked about their employment status and work productivity. The WPAI questionnaire was used to assess the impact of health on work productivity loss and impairment in daily activities \[[@b17-inj-19-2-120]\]. The WPAI questionnaire records impairment due to health problems during the past seven days and has six items grouped into four domains. Outcomes for each domain are expressed as impairment percentages, with higher scores indicating a greater proportion of impairment in work (less productivity) or activities. The four WPAI domains are described as follows: absenteeism (the percentage of work time missed due to one's health problems), presenteeism (the percentage of impairment experienced while at work due to one's health problems), overall work productivity loss (an overall impairment estimate that is a combination of absenteeism and presenteeism), and activity impairment (the percentage of impairment in daily activities due to one's health problems). Only respondents who reported being employed full-time or part-time provided data for work productivity, but all respondents provided data for activity impairment. Individuals with LUTS were also asked work productivity questions in relation to their urinary symptoms.

Depressive Symptoms
-------------------

Depressive symptoms were evaluated with the CES-D \[[@b18-inj-19-2-120]\]. The CES-D is a commonly used screening tool that assesses the presence and severity of symptoms of depression in the general population. It contains 20 items addressing depressive symptoms, and respondents indicate on a 4-point Likert scale how frequently they have experienced each symptom in the last week. Responses to items of the CES-D scale are summed up, and higher scores indicate higher levels of depressive symptoms (0=not at all depressed to 60=very depressed). In the present study, the cutoff for the selection of men with symptoms of depression was determined to be 21 points \[[@b19-inj-19-2-120]\].

Sexuality QoL
-------------

Participants were asked if they were currently sexually active. The impact of urinary symptoms on the frequency of sexual activity and on sexual enjoyment was evaluated with general questions about sexual health. Respondents were asked to rate the degree to which their urinary symptoms caused them to decrease or stop sexual activity. Those respondents who reported being sexually active were asked to rate the degree to which their urinary symptoms caused a reduction in enjoyment of sexual activity. Respondents chose from four different options for these questions: not at all, somewhat, quite a bit, and a great deal. Respondents who selected quite a bit and a great deal were considered to be negatively impacted by urinary symptoms. Respondents who reported being sexually active were also asked to rate the degree to which they were satisfied with their overall sexual life on a scale from 1 (very dissatisfied) to 5 (very satisfied). Reponses of 4 or 5 on this scale were considered indicative of satisfaction with sexual activity. The presence of ED was assessed by the validated, single-question, self-report item from the Massachusetts Male Aging Study with the following response choices: none, minimal, moderate, and complete \[[@b20-inj-19-2-120]\].

Statistical Analysis
--------------------

The impact of LUTS was assessed by comparing generic health status (EQ-5D questionnaire), work productivity (WPAI questionnaire), depressive symptoms (CES-D), and sexual health (sexual satisfaction and ED) among men with LUTS and without LUTS. Results are also reported by age groups (40--49 years, 50--59 years, and ≥60 years). Continuous variables were compared using Student t-test or the Mann-Whitney U-test, while categorical variables were compared using the chi-square test or Fisher exact test. Reliability of the questionnaire was estimated by internal consistency using Cronbach alpha coefficient. A P-value of \<0.05 was considered statistically significant. We performed all statistical analyses using the statistical software package R ver. 2.11.1 (R Foundation for Statistical Computing, Vienna, Austria).

RESULTS
=======

Of a total of 6,873 men who were contacted to participate in the study, 1,842 agreed, yielding a response rate of 26.8%, and their responses were analyzed. In our study population, 1,536 men (83.4%) who reported experiencing at least one LUTS were classified as those with LUTS. The mean age was 53.0±9.1 and 49.9±7.9 years in those with LUTS and without LUTS, respectively (P\<0.001). The prevalence of LUTS increased with age ([Fig. 1](#f1-inj-19-2-120){ref-type="fig"}). The demographic and clinical characteristics of the participants are presented in [Table 1](#t1-inj-19-2-120){ref-type="table"}.

Impact of LUTS
--------------

Regarding generic HRQoL assessed by the EQ-5D, those with LUTS had significantly lower mean EQ-5D index and VAS scores compared with those without LUTS ([Table 2](#t2-inj-19-2-120){ref-type="table"}, both P\<0.001). These results were consistent by age groups, except for the EQ-5D VAS score in men aged ≥60 years ([Tables 3](#t3-inj-19-2-120){ref-type="table"}[](#t4-inj-19-2-120){ref-type="table"}-[5](#t5-inj-19-2-120){ref-type="table"}). Cronbach alpha coefficient for the five items in the EQ-5D index was 0.619, which indicated acceptable internal consistency. In all five dimensions of the EQ-5D questionnaire, the percentages of respondents who reported either some/moderate or extreme problems were significantly different among those with LUTS and without LUTS ([Fig. 2](#f2-inj-19-2-120){ref-type="fig"}, all P\<0.001). In particular, 25.9% (398/1,536) and 25.8% (396/1,536) of individuals with LUTS reported some/moderate or extreme problems in "pain or discomfort" and "anxiety or depression," respectively.

Individuals with LUTS were significantly more likely to be unemployed than those without LUTS (27.1% vs. 17.3%, P\<0.001). For work productivity, those with LUTS had a greater impairment on all scales of the WPAI questionnaire compared with those without LUTS ([Table 2](#t2-inj-19-2-120){ref-type="table"}, all P\<0.01). Among those with LUTS, 39.2% reported any form of work impairment compared with 24.5% of those without LUTS (P\<0.001). However, there were no significant differences across groups with respect to all scales of the WPAI questionnaire among men aged ≥60 years ([Table 5](#t5-inj-19-2-120){ref-type="table"}). Additionally, among those with LUTS, 13.1% (120/914) reported always worrying about interrupting work with frequent trips to the bathroom; 2.1% (27/1,267) reported having changed jobs, retired early, or been fired because of their urinary symptoms; and 18.7% (171/914) reported that urinary symptoms were a factor in decisions related to time and location of work.

In the evaluation of depression symptoms based on the CES-D, depressive symptoms (CES-D≥21) were significantly more prevalent in those with LUTS than in those without LUTS ([Table 2](#t2-inj-19-2-120){ref-type="table"}, 11.5% vs. 2.9%, respectively, P\<0.001). However, this result was only consistent among men aged 40--49 years among the three age groups ([Table 3](#t3-inj-19-2-120){ref-type="table"}). Cronbach alpha coefficient for the 20 items in the CES-D was 0.876, which indicated good internal consistency.

With regard to sexual QoL, those with LUTS were less likely to report being currently sexually active compared with those without LUTS (54.6% vs. 68.0%, respectively, P\<0.001) ([Table 2](#t2-inj-19-2-120){ref-type="table"}). Also 17.2% and 10.6% of those with LUTS reported that urinary symptoms caused them to decrease sexual activity and decreased sexual enjoyment compared with 5.0% and 3.4% of those without LUTS, respectively (both P\<0.001). Significantly fewer individuals with LUTS indicated satisfaction with their overall sex life compared with those without LUTS (86.5% vs. 92.2%, respectively, P=0.025). The same pattern was found with respect to decreased sexual activity due to urinary symptoms in the three age groups ([Tables 3](#t3-inj-19-2-120){ref-type="table"}[](#t4-inj-19-2-120){ref-type="table"}-[5](#t5-inj-19-2-120){ref-type="table"}). However, there were no significant differences across the age groups with respect to decreased enjoyment and satisfaction of sexual activity due to urinary symptoms ([Tables 3](#t3-inj-19-2-120){ref-type="table"}[](#t4-inj-19-2-120){ref-type="table"}-[5](#t5-inj-19-2-120){ref-type="table"}). Among sexually active respondents, a significantly greater proportion of individuals with LUTS reported having moderate to complete ED relative to those without LUTS (9.0% vs. 1.0%, respectively, P\<0.001) ([Table 2](#t2-inj-19-2-120){ref-type="table"}).

DISCUSSION
==========

LUTS are highly prevalent worldwide, particularly among the elderly \[[@b8-inj-19-2-120],[@b9-inj-19-2-120],[@b12-inj-19-2-120]\]. In 2008, an estimated 1.9 billion individuals (45.2%) worldwide were affected by at least one LUTS \[[@b21-inj-19-2-120]\]. By 2018, it is estimated that around 2.3 billion individuals will be affected by at least one LUTS, and the regional burden of LUTS is expected to be greatest in Asia \[[@b21-inj-19-2-120]\]. We recently reported that the overall prevalence of at least one LUTS was estimated to be 83% in Korean men aged ≥40 years, and storage symptoms (70.1%) were more prevalent than voiding (60.4%) or postmicturition symptoms (38.3%). Nocturia (65.0%) was the most common storage symptom among participants. The most common voiding symptom was terminal dribble (49.4%), and the most common postmicturition symptom was incomplete emptying (27.2%). Combined storage and voiding symptoms were the most frequently reported combination (48.0%), and 30.2% of participants reported experiencing all three symptoms \[[@b8-inj-19-2-120]\].

Although LUTS are not life threatening, they significantly affect many dimensions of HRQoL. In this study, we addressed the individual burden of LUTS on participant-reported outcomes using clinically validated and reliable questionnaires. Our study results illustrate that LUTS are associated with poorer HRQoL. When compared with those without LUTS, those with LUTS reported a significantly lower level of overall health and work productivity, a higher level of depressive symptoms, and less sexual satisfaction. Our generic HRQoL results showed that the EQ-5D index and VAS scores were notably lower in those with LUTS than those without LUTS. In the three age groups (40--49 years, 50--59 years, and ≥60 years), a similar trend was found with respect to the EQ-5D index with significant differences. Based on the WPAI questionnaire, LUTS were associated with work productivity loss and impairment of daily activities. The work productivity loss associated with LUTS was more greatly affected by presenteeism (impairment while working) than by absenteeism (work time missed). LUTS were associated with greater overall work impairment and activity impairment (both 6% greater among those with LUTS than those without LUTS). Individuals with LUTS reported concerns related to participating in social activities and the negative effect on their daily work activities due to their urinary symptoms. These results were consistent among men aged 40--49 years and 50--59 years, but not among men aged ≥60 years. Based on the CES-D, 11.5% of those with LUTS reported having a significant level of depressive symptoms compared with 2.9% of those without LUTS. Although detailed mental health data were not collected in our survey, the results indicate that depression is a highly prevalent issue for men with LUTS. Among the three age groups, only individuals with LUTS aged 40--49 years reported a similar pattern, with significant differences in the CES-D score between those with and without LUTS. The present study also demonstrated that LUTS have been associated with decreased sexual activity and sexual satisfaction and ED. We observed that a significant percentage of those with LUTS reported that their urinary symptoms diminished the frequency of their sexual activity. Among those who were sexually active, a significant percentage of those with LUTS reported that urinary symptoms caused a reduction in their enjoyment of sexual activity and satisfaction with their overall sex lives. Furthermore, 9.0% of those with LUTS reported moderate to complete ED compared with 1.0% of those without LUTS. Although the exact relationship between male LUTS and sexual dysfunction remains unclear, recent studies have demonstrated that male LUTS are associated with decreased sexual activity and enjoyment of sex, ED, ejaculatory dysfunction, and premature ejaculation \[[@b3-inj-19-2-120],[@b22-inj-19-2-120]-[@b24-inj-19-2-120]\] Especially, Rosen et al. \[[@b22-inj-19-2-120]\] reported a relationship between LUTS and sexual dysfunction in aging men that is independent of the effects of age, other comorbidities, and lifestyle factors.

The decrease in HRQoL associated with LUTS has been reported in previous studies. A nested case-control analysis of the EPIC study, a large population-based telephone survey in Canada, Germany, Italy, Sweden, and the United Kingdom, reported the substantial impact of OAB alone and OAB with additional LUTS on work productivity, sexuality, and overall health \[[@b3-inj-19-2-120]\]. The Epidemiology of LUTS study, a cross-sectional, population-representative, internet-based survey conducted in the United States, the United Kingdom, and Sweden, also reported that HRQoL is affected by LUTS \[[@b25-inj-19-2-120]-[@b27-inj-19-2-120]\]. In these previous studies, a lower level of overall HRQoL, emotional well-being, and work productivity were noted for individuals with LUTS. Our findings are consistent with other epidemiologic studies that have reported that LUTS diminishes overall HRQoL, work productivity, depressive symptoms, and sexuality \[[@b2-inj-19-2-120],[@b3-inj-19-2-120],[@b6-inj-19-2-120],[@b22-inj-19-2-120],[@b25-inj-19-2-120]-[@b30-inj-19-2-120]\], and confirm that men with LUTS experience more impairment of HRQoL compared with those without LUTS in our study population.

HRQoL is a multidimensional concept of overall well-being and satisfaction associated with health and is determined by perceptions of physical, mental, emotional, and social health. It is becoming an important factor to consider in the management of a disease or specific condition. Given the impact of LUTS on HRQoL in the current study, a comprehensive and correct understanding of LUTS may facilitate the development of better urologic assessment and management, which could lead to improvements in population health. Strengths of our study include its population-based design and the evaluation of participants through face-to-face interviews.

There were a number of limitations to this study. This cross-sectional study only provided an association between LUTS and several dimensions of HRQoL and did not establish a cause-result relationship. The other major limitation is that a large proportion of individuals who were asked to participate declined, yielding a low response rate (26.8%). Participants were firstly selected at random. However, since participation was voluntary, it is possible that the subjects responding to our survey might be different from those who did not respond, and this may have led to a less representative general population. Additionally, the uneven distribution of those with LUTS and without LUTS needs to be considered. Because the prevalence of LUTS in men tends to increase with age, the number of men without LUTS was relatively small and this uneven distribution could have affected the observed differences.

In conclusion, this survey clearly demonstrated the substantial burden LUTS has on HRQoL, including generic QoL, work productivity, depressive symptoms, and sexual health in Korean men aged ≥40 years. The findings of our study emphasize the need for a timely and appropriate assessment and management of LUTS in order to improve HRQoL.
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###### 

Demographic data and medical comorbidities of the participants

  Characteristic                    Total participants (n=1,842)   Individuals with LUTS (n=1,536)   Individuals without LUTS (n=306)   P-value^[a)](#tfn1-inj-19-2-120){ref-type="table-fn"}^
  --------------------------------- ------------------------------ --------------------------------- ---------------------------------- --------------------------------------------------------
  Age group (yr)                                                                                                                        \<0.001
   40--49                           751 (40.8)                     588 (38.3)                        163 (53.3)                         
   50--59                           609 (33.1)                     516 (33.6)                        93 (30.4)                          
   ≥60                              482 (26.2)                     432 (28.1)                        50 (16.3)                          
  Educational level                                                                                                                     0.973
   High school graduate or less     408 (22.1)                     340 (22.1)                        68 (22.2)                          
   College or more                  1,434 (77.9)                   1,196 (77.9)                      238 (77.8)                         
  Marital status                                                                                                                        0.602
   Married or live with partner     1,670 (90.7)                   1,395 (90.8)                      275 (89.9)                         
   Single or live without partner   172 (9.3)                      141 (9.2)                         31 (10.1)                          
  Comorbidities                                                                                                                         
   Asthma                           88 (4.8)                       84 (5.5)                          4 (1.3)                            0.002
   Chronic cough                    146 (7.9)                      136 (8.9)                         10 (3.3)                           0.001
   Diabetes                         221 (12.0)                     203 (13.2)                        18 (5.9)                           \< 0.001
   High blood pressure              542 (29.4)                     475 (30.9)                        67 (21.9)                          0.002
   Neurologic disease               27 (1.5)                       24 (1.6)                          3 (1.0)                            0.605
   Depression                       119 (6.5)                      112 (7.3)                         7 (2.3)                            0.001
   Chronic constipation             114 (6.2)                      104 (6.8)                         10 (3.3)                           0.020

Values are presented as number (%).

LUTS, lower urinary tract symptoms.

Comparisons among individuals with LUTS and without LUTS

###### 

Participant-reported outcomes by all age (aged ≥40 years)

  Variable                                            Individuals with LUTS   Individuals without LUTS   P-value
  --------------------------------------------------- ----------------------- -------------------------- ---------
  EQ-5D index score (n=1,842)                         0.89±0.16               0.95±0.10                  \<0.001
  EQ-VAS score (n=1,842)                              74.9±18.8               78.0±21.9                  \<0.001
  Employment status (n=1,842)                                                                            
   Full time                                          924 (60.2)              224 (73.2)                 \<0.001
   Part time                                          196 (12.8)              29 (9.5)                   
   Not employed                                       416 (27.1)              53 (17.3)                  
  WPAI (%)                                                                                               
   Work time missed due to health (n=995)             1.4±5.3                 0.6±4.2                    0.004
   Impairment while working due to health (n=1,231)   14.5±26.6               9.3±23.7                   \<0.001
   Overall work impairment due to health (n=972)      14.1±26.0               8.3±22.5                   \<0.001
   Activity impairment due to health (n=1,667)        15.9±25.4               9.5±22.7                   \<0.001
  Any work impairment (n=1,036)                       326 (39.2)              50 (24.5)                  \<0.001
  CES-D scale ≥21 (n=1,842)                           177 (11.5)              9 (2.9)                    \<0.001
  Currently sexually active (n=1,835)                 837 (54.6)              206 (68.0)                 \<0.001
  Decreased sexual activity (n=1,835)                                                                    
   'Quite a bit' to 'a great deal'                    264 (17.2)              15 (5.0)                   \<0.001
  Decreased enjoyment of sexual activity (n=1,043)                                                       
   'Quite a bit' to 'a great deal'                    89 (10.6)               7 (3.4)                    \<0.001
  Satisfaction for sexual activity (n=1,043)          724 (86.5)              190 (92.2)                 0.025
  ED (n=1,043)                                                                                           
   'Moderately impotent' to completely impotent'      75 (9.0)                2 (1.0)                    \<0.001

Values are presented as mean±standard deviation or number (%).

LUTS, lower urinary tract symptoms; EQ-5D, EuroQoL-five dimensions; EQ-VAS, EuroQoL-visual analogue scale; WPAI, work productivity and active impairment; CES-D, center for epidemiological studies depression scale; ED, erectile dysfunction.

###### 

Participant-reported outcomes by age 40--49 years

  Variable                                          Individuals with LUTS   Individuals without LUTS   P-value
  ------------------------------------------------- ----------------------- -------------------------- ---------
  EQ-5D index score (n=751)                         0.90±0.15               0.95±0.09                  \<0.001
  EQ-VAS score (n=751)                              73.7±18.8               77.5±19.4                  0.001
  Employment status (n=751)                                                                            
   Full time                                        454 (77.2)              129 (79.1)                 0.156
   Part time                                        66 (11.2)               9 (5.5)                    
   Not employed                                     68 (11.6)               25 (15.3)                  
  WPAI (%)                                                                                             
   Work time missed due to health (n=474)           1.8±6.6                 0.4±3.2                    0.033
   Impairment while working due to health (n=579)   17.4±29.0               11.5±25.3                  0.068
   Overall work impairment due to health (n=460)    17.3±28.4               10.8±24.7                  0.034
   Activity impairment due to health (n=667)        15.2±25.0               10.8±23.3                  0.005
  Any work impairment (n=497)                       176 (45.4)              32 (29.4)                  0.009
  CES-D scale ≥ 21 (n=751)                          99 (16.8)               6 (3.7)                    \<0.001
  Currently sexually active (n=751)                 346 (58.8)              111 (68.1)                 0.111
  Decreased sexual activity (n=751)                                                                    
   'Quite a bit' to 'a great deal'                  95 (16.2)               12 (7.4)                   0.010
  Decreased enjoyment of sexual activity (n=457)                                                       
   'Quite a bit' to 'a great deal'                  39 (11.3)               5 (4.5)                    0.122
  Satisfaction for sexual activity (n=457)          296 (85.6)              102 (91.9)                 0.309
  ED (n=457)                                                                                           
   'Moderately impotent' to completely impotent'    18 (5.2)                1 (0.9)                    0.164

Values are presented as mean±standard deviation or number (%).

LUTS, lower urinary tract symptoms; EQ-5D, EuroQoL-five dimensions; EQ-VAS, EuroQoL-visual analogue scale; WPAI, work productivity and active impairment; CES-D, center for epidemiological studies depression scale; ED, erectile dysfunction.

###### 

Participant-reported outcomes by age 50--59 years

  Variable                                          Individuals with LUTS   Individuals without LUTS   P-value
  ------------------------------------------------- ----------------------- -------------------------- ---------
  EQ-5D index score (n=609)                         0.89±0.15               0.96±0.09                  \<0.001
  EQ-VAS score (n=609)                              75.6±18.5               78.6±26.1                  \<0.001
  Employment status (n=609)                                                                            
   Full time                                        358 (69.4)              74 (79.6)                  0.243
   Part time                                        54 (10.5)               9 (9.7)                    
   Not employed                                     104 (20.2)              10 (10.8)                  
  WPAI (%)                                                                                             
   Work time missed due to health (n=374)           1.1±4.1                 0.9±6.0                    1.000
   Impairment while working due to health (n=457)   11.8±23.3               5.1±18.4                   0.009
   Overall work impairment due to health (n=368)    11.1±22.3               5.6±19.6                   0.033
   Activity impairment due to health (n=561)        14.8±24.9               5.6±20.0                   \<0.001
  Any work impairment (n=387)                       111 (35.1)              14 (19.7)                  0.035
  CES-D scale ≥ 21 (n=609)                          42 (8.1)                3 (3.2)                    0.388
  Currently sexually active (n=604)                 307 (59.8)              65 (71.4)                  0.139
  Decreased sexual activity (n=604)                                                                    
   'Quite a bit' to 'a great deal'                  75 (14.6)               2 (2.2)                    \<0.001
  Decreased enjoyment of sexual activity (n=372)                                                       
   'Quite a bit' to 'a great deal'                  29 (9.5)                2 (3.1)                    0.405
  Satisfaction for sexual activity (n=372)          270 (88.0)              59 (90.8)                  1.000
  ED (n=372)                                                                                           
   'Moderately impotent' to completely impotent'    24 (7.8)                0 (0)                      0.036

Values are presented as mean±standard deviation or number (%).

LUTS, lower urinary tract symptoms; EQ-5D, EuroQoL-five dimensions; EQ-VAS, EuroQoL-visual analogue scale; WPAI, work productivity and active impairment; CES-D, center for epidemiological studies depression scale; ED, erectile dysfunction.

###### 

Participant-reported outcomes by age 60 years or older

  Variable                                          Individuals with LUTS   Individuals without LUTS   P-value
  ------------------------------------------------- ----------------------- -------------------------- ---------
  EQ-5D index score (n=482)                         0.88±0.17               0.94±0.13                  0.028
  EQ-VAS score (n=482)                              75.7±19.2               78.7±21.2                  0.142
  Employment status (n=482)                                                                            
   Full time                                        112 (25.9)              21 (42.0)                  0.048
   Part time                                        76 (17.6)               11 (22.0)                  
   Not employed                                     244 (56.5)              18 (36.0)                  
  WPAI (%)                                                                                             
   Work time missed due to health (n=147)           1.0±3.3                 0.2±0.7                    1.000
   Impairment while working due to health (n=195)   12.7±26.3               11.1±28.3                  1.000
   Overall work impairment due to health (n=144)    12.5±26.0               5.5±18.7                   1.000
   Activity impairment due to health (n=439)        18.0±26.3               14.4±24.9                  0.195
  Any work impairment (n=152)                       39 (30.5)               4 (16.7)                   0.660
  CES-D scale ≥ 21 (n=482)                          36 (8.3)                0 (0)                      0.120
  Currently sexually active (n=480)                 184 (42.7)              30 (61.2)                  0.046
  Decreased sexual activity (n=480)                                                                    
   'Quite a bit' to 'a great deal'                  94 (21.8)               1 (2.0)                    \<0.001
  Decreased enjoyment ofsexual activity (n=214)                                                        
   'Quite a bit'' to 'a great deal'                 21 (11.4)               0 (0)                      0.151
  Satisfaction for sexual activity (n=214)          158 (85.9)              29 (96.7)                  0.413
  ED (n=1,043)                                                                                         
   'Moderately impotent' to 'completely impotent'   33 (17.9)               1 (3.3)                    0.167

Values are presented as mean±standard deviation or number (%).

LUTS, lower urinary tract symptoms; EQ-5D, EuroQoL-five dimensions; EQ-VAS, EuroQoL-visual analogue scale; WPAI, work productivity and active impairment; CES-D, center for epidemiological studies depression scale; ED, erectile dysfunction.

[^1]: Tae Heon Kim and Deok Hyun Han contributed equally to this study as co-first authors.
